Laura Joszt, MA

Laura Joszt headshot

Laura Joszt, MA, is the content director for The American Journal of Managed Care®. She has been with MJH Life Sciences since 2011.

Laura has an MA in business and economic reporting from New York University. You can connect with Laura on LinkedIn or Twitter.

Articles by Laura Joszt, MA

The Robert Wood Johnson Foundation has named its new president and CEO. Richard Besser, MD, who will succeed Risa Lavizzo-Mourey, MD, who ran the foundation for 14 years before announcing she was stepping down in September 2016.

Now that the Senate has confirmed US Rep. Tom Price, R-Georgia, as HHS secretary, Republicans will start to look toward making changes to the Affordable Care Act and Medicaid. Here is a look at block grants, which the GOP is considering using to reform the Medicaid program.

A new healthcare reform legislation was introduced Monday by Bill Cassidy, MD, R-Louisiana, and Susan Collins, R-Maine. The proposed Patient Freedom Act would not fully repeal the Affordable Care Act (ACA), but instead, would place more power in the hands of the states by giving them the option of staying with the ACA or choosing another option.

Rising healthcare expenditures, leading to increased consumer cost sharing, is a top concern in healthcare that crosses party lines. In a new commentary in JAMA Internal Medicine, A. Mark Fendrick, MD, and Michael E. Chernew, PhD, co-editors-in-chief of The American Journal of Managed Care, highlighted the need for a “smarter” deductible.

As the team at CMS prepares to hand the reins over to the next administration, Andy Slavitt, acting administrator of CMS, took the time to speak with Mandi Bishop, MA, CEO of Aloha Health, in the latest podcast of Managed Care Cast about what he learned in his role and what the next administration should keep in mind.

January 1, 2017, marks the beginning of a new way of being paid in Medicare. And while the final rule of MACRA was released in October, and many providers and practices are still trying to parse out what it will mean to them.

Although chronic obstructive pulmonary disease (COPD) remains a leading cause of death around the world, the reason for why patients with COPD lose the ability to repair damage to their lungs is poorly defined. However, researchers at the Helmholtz Zentrium München may now have an idea of why this happens.